Get the Stockscreener App
290.60
2.50%
-7.44
After Hours:
292.00
1.40
+0.48%
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $290.60, with a volume of 947.80K.
It is down -2.50% in the last 24 hours and up +6.44% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$298.04
Open:
$301.02
24h Volume:
947.80K
Relative Volume:
0.50
Market Cap:
$34.95B
Revenue:
$123.11B
Net Income/Loss:
$1.58B
P/E Ratio:
22.30
EPS:
13.0294
Net Cash Flow:
$2.44B
1W Performance:
+13.24%
1M Performance:
+6.44%
6M Performance:
+1.78%
1Y Performance:
+18.39%
1-Day Range:
$290.06
$301.02
1-Week Range:
$255.01
$302.79
52-Week Range:
$206.87
$315.35
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
500 W MAIN ST, LOUISVILLE, KY
Compare HUM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
290.60 | 35.85B | 123.11B | 1.58B | 2.44B | 13.03 |
|
UNH
Unitedhealth Group Inc
|
367.69 | 335.03B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CVS
Cvs Health Corp
|
76.74 | 97.57B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
CI
Cigna Group
|
306.13 | 81.88B | 261.22B | 5.40B | 3.94B | 18.31 |
|
ELV
Elevance Health Inc
|
358.13 | 81.59B | 189.25B | 5.35B | 5.34B | 23.49 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
CVS, UnitedHealth, Elevance, Humana Gain Price Target Hikes Wall Street After Medicare Star Ratings Update - MSN
Humana, Aetna fall in 2026 Medicare Advantage star ratings - Modern Healthcare
Humana hosts open house to help navigate health insurance changes - WKRC
How Humana’s Rich Blanchard helps D.C. employers create benefits packages that attract and retain top talent - The Business Journals
Why Humana (HUM) is a Top Value Stock for the Long-Term - sharewise.com
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, - GlobeNewswire
Analyst Mizuho Raises Humana (HUM) Price Target to $345 | HUM St - GuruFocus
Mizuho Adjusts Price Target on Humana to $345 From $300, Maintains Outperform Rating - MarketScreener
Is Humana Inc. stock oversold or undervaluedExit Point & High Accuracy Buy Signal Tips - newser.com
Order flow analysis tools used on Humana Inc.Weekly Loss Report & Risk Adjusted Swing Trade Ideas - newser.com
Will Humana Inc. stock benefit from upcoming earnings reportsWeekly Gains Report & Detailed Earnings Play Strategies - newser.com
Using Python tools to backtest Humana Inc. strategies2025 Macro Impact & Breakout Confirmation Trade Signals - newser.com
How to escape a deep drawdown in Humana Inc.2025 Market WrapUp & Long-Term Capital Growth Strategies - newser.com
Humana's (HUM) Sell (D+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Humana says talks with Mercy Health still ongoing - The Paducah Sun
Humana’s SWOT analysis: medicare giant faces stars challenge, seeks growth - Investing.com
Bon Secours may become out-of-network care for SC residents on Medicaid, Medicare - Greenville Online
Mercy Health threatens to terminate Humana contract for Medicaid, Medicare Advantage plans - LimaOhio.com
HUMANA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
HUMANA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Major Insurers Scale Back Medicare Advantage and Part D Plans for 2026 - Kiplinger
Mercy Health continues negotiations with Humana - Spectrum News
Bon Secours, Humana negotiations could impact patient coverage - WAVY.com
Janney Montgomery Scott LLC Increases Stock Position in Humana Inc. $HUM - MarketBeat
Mercy Health Alerts Humana Patients as Contract Negotiations Enter New Phase - Warren County Post
Mercy Health warns Humana patients could lose in-network access by December - WTOL
16K+ Bon Secours patients at risk amid Humana contract dispute - wspa.com
Kettering Health to part ways with Humana, Devoted Health in 2026 - WDTN.com
Mercy Health warns it may drop Humana Medicaid and Medicare Advantage - Dayton Daily News
Mercy Health may lose contracts for Humana Medicaid, Medicare Advantage patients - Yahoo
Mercy Health could soon be out of network for patients with Humana Medicaid - WKBN.com
Kettering Health to part ways with HUMANA and DEVOTED in 2026 - WDTN.com
Humana (HUM): Exploring Valuation Following Recent Share Price Stability - simplywall.st
Thousands with Medicare and Medicaid in Upstate SC may see higher costs amid contract dispute - Post and Courier
Humana: Pickleball Is Gateway To Better Health 10/08/2025 - MediaPost
Analyst Stephen Baxter from Wells Fargo Raises Humana (HUM) Pric - GuruFocus
Humana (HUM): Evaluating Valuation After Jump in Higher-Rated Medicare Advantage Enrollment and Raised Guidance - Yahoo
Humana Inc. (HUM) Elliott Wave forecast: Wave IV correction nearing completion - FXStreet
Important Notice to Long-Term Shareholders of Humana Inc. - GlobeNewswire
Wells Fargo Adjusts Humana Price Target to $347 From $344 - MarketScreener
Bon Secours alerts Humana patients as contract negotiations enter new phase - FOX Carolina
Something unusual just showed up in Medicare’s 2026 preview - TheStreet
Humana Inc. $HUM Shares Bought by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Humana Inc. (NYSE:HUM) Receives Average Rating of "Hold" from Brokerages - MarketBeat
2 Firms To Lead Humana Investor Suit Over Post-COVID Costs - Law360
Humana Inc. stock outperforms competitors on strong trading day - MSN
Humana responds to Kettering Health ending Medicare Advantage contract - Yahoo
Signal strength of Humana Inc. stock in tech scanners2025 Geopolitical Influence & Intraday High Probability Alerts - newser.com
Important Notice to Long-Term Shareholders of Fluor Corporation (NYSE: FLR); Humana Inc. (NYSE: HUM); Maison Solutions Inc. (NASDAQ: MSS); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire
How Humana Inc. (HUM) stock correlates with oil marketsTrade Analysis Report & AI Enhanced Trading Signals - newser.com
Wolfe Research Adjusts Price Target on Humana to $313 From $283, Maintains Outperform Rating - MarketScreener
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):